All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2025-P-1242
Request that the FDA immediately suspend the approval of mifepristone (brand name: Mifeprex) for use in chemical abortions until a comprehensive safety review can be conducted under current real-world prescribing conditions.
Documents
4
Comments
7
Description
OPEN
Key Dates
Comment Period OpensMay 14, 2025
Documents
| Type | Title | Status |
|---|---|---|
Other |
Comment Statistics
Total Comments
7
Keywords
CDER
Citizen Petition
immediately suspend the approval of
mifepristone (brand name: Mifeprex)
for use in chemical abortions until a
comprehensive safety review can be conducted
under current real-world prescribing conditions.
OPEN
Data from Regulations.gov